Sort
30,917 grants matching “tumor microenvironment”
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2022 · NS
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2021 · NS
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2023 · NS
Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis
$403,419Xiaohong Li · University Of Toledo Health Sci Campus · R01 · FY2020 · CA
Mouse models of glioma to study functional exRNA transfer to the microenvironmen
$403,400Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2016 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$403,393Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2025 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$403,366Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2022 · CA
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
$403,238Soldano Ferrone · Massachusetts General Hospital · R01 · FY2018 · DE
The Role of FOXCI in Basal-like Breast Cancer
$403,156Xiaojiang Cui · Cedars-Sinai Medical Center · R01 · FY2019 · CA
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$403,147Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
(PQ1) Epigenetic effects of the premalignant field
$403,131Lance S Terada · Ut Southwestern Medical Center · R01 · FY2019 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$403,102Trudy Gale Oliver · Duke University · R01 · FY2023 · CA
Age-related shifts in epithelial lineages and tissue homeostasis in mammary gland
$403,069Mark A Labarge · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2011 · AG
Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs
$403,050Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Targeting macrophage reprogramming in glioblastoma
$403,028Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Project 5 - EBV Drivers of Oncogenesis and Novel Therapies
$403,005Shannon Celeste Kenney · University Of Wisconsin-Madison · P01 · FY2022 · CA
Role of senescence in multiple myeloma tumorigenesis
$402,991Megan M Weivoda · Mayo Clinic Rochester · U01 · FY2022 · AG
Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment
$402,968Tianyan Gao · University Of Kentucky · R01 · FY2025 · CA
Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment
$402,968Tianyan Gao · University Of Kentucky · R01 · FY2024 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$402,938Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2020 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$402,938Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2021 · CA
Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition
$402,824Robert M Prins · University Of California Los Angeles · P50 · FY2025 · CA
Tubulin microtentacles in detached mammary epithelial cells
$402,817Stuart S Martin · University Of Maryland Baltimore · R01 · FY2024 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$402,801Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$402,791Michael Lim · Stanford University · R01 · FY2022 · NS